Davis Investment Partners’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$521K Buy
6,593
+26
+0.4% +$2.21K 0.16% 102
2026
Q1
$566K Sell
6,567
-3,050
-32% -$274K 0.2% 95
2025
Q4
$840K Buy
+9,617
New +$730K 0.29% 59

Other funds holding GMED

Davis Investment Partners's GMED Position: Q2 2026 in Review

Davis Investment Partners increased its Globus Medical (GMED) stake by 0.4% in Q2 2026, buying an estimated $2.21K and bringing the position to 6,593 shares worth $521K. The position accounts for 0.16% of the portfolio, ranked #102.

Davis Investment Partners first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $840K in Q4 2025. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Davis Investment Partners held 6,593 shares of Globus Medical worth $521K as of Q2 2026.
  • Davis Investment Partners bought 26 Globus Medical shares in Q2 2026, an estimated $2.21K.
  • Globus Medical made up 0.16% of Davis Investment Partners's portfolio in Q2 2026, its #102 holding.
  • Davis Investment Partners first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Davis Investment Partners's Globus Medical position peaked at $840K in Q4 2025.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Davis Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.